The goal of clinical trials is no longer only about showing efficacy and safety, but now must also demonstrate comparative efficacy to reimbursement agencies. Clinical trials need to be designed with both regulatory agencies and market access in mind. See more here. (Source: Context Matters, 12/17/14)
You are here: / / How Important Is Trial Design In Attaining Market Access?